Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis in Wire-localized Lumpectomy
NCT04818931Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Apr 2018
- Primary completion
- Jun 2019
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, single-blind trial of cefazolin in surgical site infection (SSI) (2 arms), sponsored by CHU de Québec-Université Laval. Primary endpoint: Number of participants with surgical site infection at 30 days. Started Apr 2018; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04818931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818931.